The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Regulatory News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

“First US Integumen COVID19 detection agreement”

30 Sep 2020 07:00

RNS Number : 5053A
Integumen PLC
30 September 2020
 

AIM share code: SKIN

30 September 2020

 

Integumen PLC (to be renamed DeepVerge plc)

 

("Integumen" or "Company")

 

First COVID19 detection agreement for Detroit MI and Fresh Water in Great Lakes, USA

 

Integumen and Water Rising Institute in 3-year Great Lakes water contamination detection Project

 

Deployment of Microtox® PD and Microtox® BT Novel Sensors for identification of pathogenic virusesincluding SARS-CoV-2

 

Integumen announces that it has signed an Memorandum of Understanding ("MoU") with Water Rising Institute, a Non Profit Organization in Detroit, Michigan, USA, to enter a legally binding three year Framework Agreement ("Agreement") to be executed on or before the 18 November 2020 for the supply of $500,000 of equipment, consumables and services from ecowaterOS partners, for the management and real-time monitoring of water quality, initially in the Great Lakes basin region of Michigan.

 

WaterRising Institute is a women-led nonprofit that accelerates real-time and sustainable management of water. WaterRising aims to develop a state-of-the-art early warning system for water quality monitoring, that provides real time alerts, enabling the local authorities to identify the source of their pollutants, while protecting their citizens.

 

Under the proposed Agreement Integumen will act for and on behalf of the Consortium Parties of ecowaterOS technologies in the USA, EU and associated states under the European Neighbourhood Policy who provide products and services. The appointment to manage the water systems will continue for three years, with an initial trial period of six months, and an annual renewal thereafter.

 

Integumen will act as WaterRising's agent to design, build, install and supervise the Detroit River AI Water Quality Project ('DRAWQ[i]'). The DRAWQ project consists of a Consortium Parties of ecowaterOS technologies in the USA, EU and associated states under the European Neighbourhood Policy. Monitoring products will include ecowaterOS partner's HydrolightTM, RAWTestTM, Microtox®, OVA®, PDV®, RaPID Assay®, EnviroGard®, EnSys®, QuickChek®, AlgaeChek®, BODChek®, PetroChek®. Integumen's Microtox® PD and Microtox® BT Novel Sensors will be used for the identification of pathogenic viruses including SARS-CoV-2.

 

Gerard Brandon CEO Integumen plc commented:

 

"WaterRising Institute is an inspiring consortium driving recognition of the importance of clean water and we are delighted to be working alongside them in the DRAWQ Project. More than 35 million people rely on the Great Lakes for drinking water, jobs and their way of life and right now there are 90 Million Cases of Recreational Waterborne Illness Per Year[ii], clearly demonstrating the need to rejuvenate the river. This work will enable Detroit to become the center of excellence for technology and systems for the measuring of water quality and we are proud to be a part of this drive for environmental change."

 

Alicia Douglas, President of Water Rising Institute comments: 

"We are excited to be partnering with Integumen, as we are directly aligned on our goals to bring innovation and technology to the infrastructure of our water systems, to protect our people and our planet. The DRAWQ project launches this much needed real-time AI technology in Detroit, MI. WaterRising Institute will then help to spread this and many other real-time water monitoring and warning solutions to other parts of the US and the world"

 

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Integumen plc

Gerard Brandon, CEO

 

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050

 

About Integumen plc (www.integumen.com)

Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time. Shareholders approved the change of name to DeepVerge plc in general meeting on 24 September 2020. The Company awaits confirmation of the change of name from the Registrar of Companies.

 

About Water Rising Institute (www.waterrisinginstitute.org)

WaterRising Institute is a women-led non-profit that accelerates real-time and sustainable management of water that is secure for people and the planet, through innovation, investment partnerships and water literacy.

 

Its approach is systems-based, global and people-focused, with emphasis on equity, security, collaboration, societal benefits, return-on-investment and the value of water.

 

Water Rising Institute believes that through our strong partnerships with academia, organizations (public, private, and philanthropic), and community scientists it can create a network of tools, technologies and people to solve current and emerging water quality threats in the Great Lakes region initially as well as positively influencing water sources nationally and globally in the longer term.

 

About EcoSystemOS (www.ecosystemOS.com)

Developed by the Rinocloud division of Integumen, this is a consortium of partners operating a live dynamic water management system that delivers safe clear water from rivers to wastewater treatment plants using Artificial Intelligence to provide instant alerts from remote sensors direct to stakeholders. It continuously evolves, learns and improves by bringing together multiple existing and smart technologies to create efficient water and deliver environmental protection. Over-the-air monitoring keeps stakeholders constantly up to date with web and mobile alert applications adapted for each group.

 

 

[i] DRAWQ: Detroit River AI Water Quality

[ii] https://ehjournal.biomedcentral.com/articles/10.1186/s12940-017-0347-9

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRUKOWRRVUKUAR
Date   Source Headline
28th Apr 20204:37 pmRNSPrice Monitoring Extension
28th Apr 20202:05 pmRNSSecond Price Monitoring Extn
28th Apr 20202:00 pmRNSPrice Monitoring Extension
17th Apr 20202:06 pmRNSSecond Price Monitoring Extn
17th Apr 20202:00 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSUpdate re COVID 19; confirmed orders; investment
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
18th Mar 202010:22 amRNSDirector/PDMR Shareholding
18th Mar 20207:00 amRNS3 year $3.75m (£3.12m) bacteria prod'n agreement
12th Mar 20202:06 pmRNSSecond Price Monitoring Extn
12th Mar 20202:00 pmRNSPrice Monitoring Extension
26th Feb 20207:00 amRNSLaunch of ecowaterOS; Company Update
7th Feb 20207:00 amRNSIntegumen plc to present at The UK Investor Show
3rd Feb 20207:00 amRNSCommercial & AI partnership with Acumen Software
21st Jan 20207:00 amRNSCooperative Alliance; Trading Update
19th Dec 20197:00 amRNS3-year Rev sharing Framework Ag with Parity Group
16th Dec 20198:43 amRNSDirector/PDMR Shareholdings
9th Dec 201911:05 amRNSPlacing/Subscription to raise £1.368m -replacement
9th Dec 20197:00 amRNSPlacing and subscription to raise £1.368 million
20th Nov 20197:00 amRNSResults of AI water research project
13th Nov 20197:00 amRNSHeads of Terms -Framework Agreement;trading update
7th Nov 20197:00 amRNSMicrobiome and Labskin clone R&D agreements signed
29th Oct 20197:00 amRNSLaunch of ind. Rinodrive AI open-source eco-system
21st Oct 20197:00 amRNSRinocloud subsidiary wins "One To Watch" IT award
8th Oct 201912:34 pmRNSIssue of Equity: Shares in Lieu of Invoice
7th Oct 20197:00 amRNSLabskin signs multi-year service agreement
7th Oct 20197:00 amRNSLabskinAI creates virtual AI psoriasis skin model
11th Sep 20197:00 amRNSInterim Results
5th Sep 20197:00 amRNSLabskin breakthrough clones 16 human skin swabs
2nd Aug 20197:00 amRNSHighlands Nat. Resources agreement with Cellulac
1st Aug 20191:41 pmRNSExercise of Warrants
1st Aug 201911:32 amRNSExercise of Warrants
31st Jul 20194:30 pmRNSResult of AGM
31st Jul 20197:00 amRNSAGM - Trading Update
29th Jul 20197:00 amRNSCollaboration; Expansion of wound care division
19th Jul 20197:00 amRNSLabskinAI:agreementswith global cosmetic companies
12th Jul 20197:00 amRNSChange to interests of a significant shareholder
11th Jul 201910:38 amRNSExercise of Warrants (update)
10th Jul 201912:55 pmRNSExercise of warrants
8th Jul 20197:00 amRNSAGM Notice and Trading Update
28th Jun 20193:03 pmRNSExercise of Warrants
27th Jun 20197:00 amRNSFinal Results
21st Jun 20197:00 amRNSExercise of Warrants
20th Jun 20197:01 amRNSExecutive team and Labskin AI digital hub updates
20th Jun 20197:00 amRNSExercise of Warrants
10th Jun 20197:00 amRNSExercise of Warrant Shares and Call Option Shares
28th May 20197:30 amRNSExercise of Warrants
28th May 20197:00 amRNSNew Labskin AI contracts; additional lab space
21st May 20197:00 amRNSTrading update and Board changes
10th May 201912:19 pmRNSLaunch of Labskin human skin clone tests

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.